SBIR-STTR Award

Multi Injection Vial Anti-contamination cap (MIVA-Cap)
Award last edited on: 9/5/22

Sponsored Program
SBIR
Awarding Agency
DOD : CBD
Total Award Amount
$167,470
Award Phase
1
Solicitation Topic Code
CBD212-004
Principal Investigator
Kirk Whitener

Company Information

ChromoLogic LLC

1225 Shamrock Avenue
Monrovia, CA 91106
   (626) 381-9974
   info@chromologic.com
   www.chromologic.com
Location: Single
Congr. District: 31
County: Los Angeles

Phase I

Contract Number: W911SR-22-P-0002
Start Date: 2/14/22    Completed: 8/13/22
Phase I year
2022
Phase I Amount
$167,470
To meet CBD’s need for a multi-dose formulation of scopolamine hydrobromide trihydrite ChromoLogic proposes to develop a vial add-on containing a self-decontamination cap with a self-healing material to eliminate evaporation and contamination risks through needle punctures in the septum. CL will also perform forced degradation and stability tests with a panel of preservatives to select optimal preservative/concentration and achieve target shelf-life. Overall, CL plans to work with the CBD to ensure this product is an amendment to their already existing FDA process for approval of their single-dose formulation

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----